Picture of Arecor Therapeutics logo

AREC Arecor Therapeutics Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Arecor Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
May 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments0.7053.072.918.312.8
Net Total Accounts Receivable
Net Total Receivables0.7590.8110.861.572.82
Total Inventory
Prepaid Expenses
Total Current Assets1.523.923.8220.517.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.4390.2950.3750.3280.838
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets2.074.314.2820.921.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.8231.041.412.273.73
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities1.41.13.512.374.31
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.673.210.77418.517.5
Total Liabilities & Shareholders' Equity2.074.314.2820.921.8
Total Common Shares Outstanding